Crescera Capital Acquisition Corp. (NASDAQ:CREC – Get Rating) was the target of a significant drop in short interest in the month of October. As of October 31st, there was short interest totalling 1,000 shares, a drop of 44.4% from the October 15th total of 1,800 shares. Based on an average daily trading volume, of 40,700 shares, the short-interest ratio is currently 0.0 days.
Crescera Capital Acquisition Stock Performance
Shares of NASDAQ CREC remained flat at $10.14 during mid-day trading on Friday. 4 shares of the company traded hands, compared to its average volume of 56,451. The firm's 50 day moving average price is $10.07 and its 200-day moving average price is $9.99. Crescera Capital Acquisition has a twelve month low of $9.79 and a twelve month high of $10.14.
Get Crescera Capital Acquisition alerts:Institutional Investors Weigh In On Crescera Capital Acquisition
Several hedge funds have recently made changes to their positions in CREC. State Street Corp acquired a new position in Crescera Capital Acquisition in the second quarter worth about $126,000. Wealthspring Capital LLC acquired a new position in Crescera Capital Acquisition in the second quarter worth about $130,000. Robinson Capital Management LLC acquired a new position in Crescera Capital Acquisition in the second quarter worth about $177,000. Berkley W R Corp acquired a new position in Crescera Capital Acquisition in the first quarter worth about $244,000. Finally, Bank of Montreal Can acquired a new position in Crescera Capital Acquisition in the first quarter worth about $247,000.
Crescera Capital Acquisition Company Profile
(Get Rating)
Crescera Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar combination with one or more businesses in technology, healthcare, education services, consumer, and retail sectors in Latin America.
Read More
- Get a free copy of the StockNews.com research report on Crescera Capital Acquisition (CREC)
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
Receive News & Ratings for Crescera Capital Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescera Capital Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
